1. BLU-701 tumour suppression and intracranial activity as a single agent and in combination with BLU-945 in models of non-small cell lung cancer (NSCLC) driven by EGFR mutations. (March 2022) Authors: Tavera, Luz; Zhang, Zhuo; Wardwell, Scott; Job, Ebby; McGinn, Katie; Chen, Maxine; Iliou, Maria; Albayya, Faris; Campbell, John; Eno, Meredith; Fernando, Dilinie; Dineen, Tom; Ahmad, Omar; Wilson, Douglas; Barvian, Kevin; Hsieh, John; Medendorp, Clare; Timsit, Yoav; Guo, Jian; Perez, Nisha Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗